Okomera
Pre-clinicalOkomera is developing an innovative approach to accelerate the development of personalized cancer treatments. The technology allows to test a panel of potential therapies (chemotherapy, immunotherapy, cell therapy, combined therapies) on the patient's cells derived from tumor biopsy and cultured in 3D-spheroids on microfluidic chips.
About
Okomera is developing an innovative approach to accelerate the development of personalized cancer treatments. The technology allows to test a panel of potential therapies (chemotherapy, immunotherapy, cell therapy, combined therapies) on the patient's cells derived from tumor biopsy and cultured in 3D-spheroids on microfluidic chips.
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile